Zalutumumab in Combination With Chemo-Radiation in a Certain Type of Lung Cancer

NCT00460551 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
13
Enrollment
INDUSTRY
Sponsor class

Stopped Due to considerations regarding the appropriate therapeutic regimen for these patients.

Conditions

Interventions

Sponsor

Genmab